Cargando…
Proteomics in Pancreatic Cancer Research
Pancreatic cancer is a highly aggressive malignancy with a poor prognosis and deeply affects the life of people. Therefore, the earlier diagnosis and better treatments are urgently needed. In recent years, the proteomic technologies are well established and growing rapidly and have been widely appli...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200191/ https://www.ncbi.nlm.nih.gov/pubmed/22084685 http://dx.doi.org/10.1155/2011/365350 |
_version_ | 1782214667816402944 |
---|---|
author | Geng, Ruihui Li, Zhaoshen Li, Shude Gao, Jun |
author_facet | Geng, Ruihui Li, Zhaoshen Li, Shude Gao, Jun |
author_sort | Geng, Ruihui |
collection | PubMed |
description | Pancreatic cancer is a highly aggressive malignancy with a poor prognosis and deeply affects the life of people. Therefore, the earlier diagnosis and better treatments are urgently needed. In recent years, the proteomic technologies are well established and growing rapidly and have been widely applied in clinical applications, especially in pancreatic cancer research. In this paper, we attempt to discuss the development of current proteomic technologies and the application of proteomics to the field of pancreatic cancer research. This will explore the potential perspective in revealing pathogenesis, making the diagnosis earlier and treatment. |
format | Online Article Text |
id | pubmed-3200191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-32001912011-11-14 Proteomics in Pancreatic Cancer Research Geng, Ruihui Li, Zhaoshen Li, Shude Gao, Jun Int J Proteomics Review Article Pancreatic cancer is a highly aggressive malignancy with a poor prognosis and deeply affects the life of people. Therefore, the earlier diagnosis and better treatments are urgently needed. In recent years, the proteomic technologies are well established and growing rapidly and have been widely applied in clinical applications, especially in pancreatic cancer research. In this paper, we attempt to discuss the development of current proteomic technologies and the application of proteomics to the field of pancreatic cancer research. This will explore the potential perspective in revealing pathogenesis, making the diagnosis earlier and treatment. Hindawi Publishing Corporation 2011 2011-08-14 /pmc/articles/PMC3200191/ /pubmed/22084685 http://dx.doi.org/10.1155/2011/365350 Text en Copyright © 2011 Ruihui Geng et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Geng, Ruihui Li, Zhaoshen Li, Shude Gao, Jun Proteomics in Pancreatic Cancer Research |
title | Proteomics in Pancreatic Cancer Research |
title_full | Proteomics in Pancreatic Cancer Research |
title_fullStr | Proteomics in Pancreatic Cancer Research |
title_full_unstemmed | Proteomics in Pancreatic Cancer Research |
title_short | Proteomics in Pancreatic Cancer Research |
title_sort | proteomics in pancreatic cancer research |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200191/ https://www.ncbi.nlm.nih.gov/pubmed/22084685 http://dx.doi.org/10.1155/2011/365350 |
work_keys_str_mv | AT gengruihui proteomicsinpancreaticcancerresearch AT lizhaoshen proteomicsinpancreaticcancerresearch AT lishude proteomicsinpancreaticcancerresearch AT gaojun proteomicsinpancreaticcancerresearch |